Damages in Life-Cycle Management Case
Cornerstone Research assisted counsel in evaluating possible damages in a case where a branded pharmaceutical company was accused of delaying generic competition through various mechanisms.
Delayed Generic Competition
Counsel for a generic pharmaceutical company retained Cornerstone Research to assess the company’s incentives to launch a generic drug while ongoing patent litigation remained unresolved.
Exclusionary Practices in Managed Care Organizations’ Contracts
Cornerstone Research worked with the defense experts in a series of antitrust cases against the manufacturer of a branded drug with a dominant market share in its therapeutic class.
Hilton v. Children’s Hospital San Diego
Counsel for the defendants retained Dr. Michael Keeley, a senior vice president of Cornerstone Research, to evaluate the plaintiff’s antitrust claims from an economic perspective and to assess the validity…
How can we help you?
If you are looking for a publication not on our website, contact us.